1 / 12

Patrick An Introduction to Medicinal Chemistry 3/e Chapter 22 ANTIULCER AGENTS

Patrick An Introduction to Medicinal Chemistry 3/e Chapter 22 ANTIULCER AGENTS Part 3: Proton pump inhibitors. Contents Part 3: Proton pump inhibitors 23. Parietal Cells and the Proton Pump 24. Proton Pump Inhibitors 25. Mechanism of inhibition 26. Design of omeprazole (Losec)

sydnee-bennett
Download Presentation

Patrick An Introduction to Medicinal Chemistry 3/e Chapter 22 ANTIULCER AGENTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Patrick An Introduction to Medicinal Chemistry 3/e Chapter 22 ANTIULCER AGENTS Part 3: Proton pump inhibitors

  2. Contents Part 3: Proton pump inhibitors 23. Parietal Cells and the Proton Pump 24. Proton Pump Inhibitors 25. Mechanism of inhibition 26. Design of omeprazole (Losec) 26.1. The lead compound 26.2. Modification of the thiourea group 26.3. Modify the imidazole ring 26.4. Drug metabolism studies 26.5. Add substituents to the heterocyclic rings 26.6. Substituents varied on the pyridine ring 26.7. Substituents varied on the benzimidazole ring 27. Esomeprazole (Nexium) 28. Synthesis of Omeprazole [11 slides]

  3. M3 H2 Cck2 ATP ADP + Pi Receptors Proton pump + Ion channels + H K - Cl Canaliculus HCl Lumen of the stomach 23. Parietal Cells and the Proton Pump • The proton pump • Pumps protons out of the parietal cell and potassium ions back in • Requires energy - provided by hydrolysis of ATP to ADP, catalysed by ATPase • The proton pump is also called H+/K+-ATPase • Chloride ions depart through a separate ion channel • HCl is formed in the canaliculus • The potassium ions exit the parietal cell as counterions for the chloride ions and are then pumped back in • A separate potassium ion channel is used for K+ ions leaving the cell

  4. 24. Proton Pump Inhibitors • Act as prodrugs • Activated by strongly acidic conditions found in the canaliculae of parietal cells

  5. 25. Mechanism of inhibition

  6. 26. Design of omeprazole (Losec) 26.1. The lead compound • Originally an antiviral drug • Inhibits gastric acid secretion • Liver toxicity due to the thioamide group 26.2. Modification of the thiourea group • Inhibits gastric acid secretion • The pyridine ring and bridging CH2S moiety are important to activity

  7. 26. Design of omeprazole (Losec) 26.3 Modify the imidazole ring • Increase in activity due to the benzimidazole ring 26.4 Drug metabolism studies • Timoprazole formed by metabolism of H124/26 • Timoprazole is the active drug • Pyridinylmethylsulfinyl benzimidazole structure • Side effect - inhibits iodine uptake by the thyroid gland

  8. 26. Design of omeprazole (Losec) 26.5 Add substituents to the heterocyclic rings • Potent antisecretory properties over long periods of time • No toxic side effects on the thyroid • No other serous side effects

  9. 26. Design of omeprazole (Losec) 26.6 Substituents varied on the pyridine ring • Substituents which increase the basicity of the pyridine ring are good for activity • Promotes the mechanism of activation • Methyl substituents at the meta position have an inductive effect • Methoxy substituent are more effective at para position than meta position • Resonance effect increases electron density on the nitrogen • H159/69 is potent but chemically too labile

  10. 26. Design of omeprazole (Losec) 26.7 Substituents varied on the benzimidazole ring • Substituents were varied to get the right balance of potency, chemical stability and synthetic accessibility • Omeprazole was found to have the best balance • Launched in 1988 by Astra • World’s biggest selling drug

  11. 27. Esomeprazole (Nexium) • Omeprazole has an asymmetric centre • The S-enantiomer has better potency and pharmacokinetic profile • Example of chiral switching

  12. N a O H 28. Synthesis of Omeprazole

More Related